Your browser doesn't support javascript.
loading
Validation of the Prognostic Utility of ESTRO/EORTC Oligometastatic Disease Classification: A Secondary Analysis From the Population-Based Phase II SABR-5 Trial.
Baker, S; Mou, B; Jiang, W; Liu, M; Bergman, A M; Schellenberg, D; Alexander, A S; Carolan, H; Atrchian, S; Berrang, T; Bang, A; Chng, N; Matthews, Q; Tyldesley, S; Olson, R A.
Affiliation
  • Baker S; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Surrey, British Columbia, Canada.
  • Mou B; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Kelowna, British Columbia, Canada.
  • Jiang W; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Surrey, British Columbia, Canada.
  • Liu M; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Vancouver, British Columbia, Canada.
  • Bergman AM; Departement of Cancer, University of British Columbia, BC Cancer - Vancouver, British Columbia, Canada.
  • Schellenberg D; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Surrey, British Columbia, Canada.
  • Alexander AS; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Victoria, British Columbia, Canada.
  • Carolan H; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Vancouver, British Columbia, Canada.
  • Atrchian S; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Kelowna, British Columbia, Canada.
  • Berrang T; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Victoria, British Columbia, Canada.
  • Bang A; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Victoria, British Columbia, Canada.
  • Chng N; Departement of Cancer, University of British Columbia, BC Cancer - Prince George, British Columbia, Canada.
  • Matthews Q; Departement of Cancer, University of British Columbia, BC Cancer - Prince George, British Columbia, Canada.
  • Tyldesley S; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Vancouver, British Columbia, Canada.
  • Olson RA; Departement of Cancer, University of British Columbia, British Columbia, Canada; Departement of Cancer, University of British Columbia, BC Cancer - Prince George, British Columbia, Canada. Electronic address: rolson2@bccancer.bc.ca.
Int J Radiat Oncol Biol Phys ; 114(5): 849-855, 2022 12 01.
Article in En | MEDLINE | ID: mdl-36302495

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiosurgery / Neoplasms Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Country/Region as subject: America do norte Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiosurgery / Neoplasms Type of study: Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Country/Region as subject: America do norte Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2022 Document type: Article Affiliation country: Country of publication: